CROCETTA, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 2.061
AS - Asia 936
EU - Europa 818
Continente sconosciuto - Info sul continente non disponibili 168
SA - Sud America 86
AF - Africa 18
Totale 4.087
Nazione #
US - Stati Uniti d'America 1.993
SG - Singapore 455
CN - Cina 212
IT - Italia 182
IE - Irlanda 121
SE - Svezia 117
RU - Federazione Russa 114
VN - Vietnam 95
GB - Regno Unito 78
BR - Brasile 64
UA - Ucraina 57
TR - Turchia 45
DE - Germania 38
FR - Francia 36
HK - Hong Kong 33
CA - Canada 26
IN - India 22
MX - Messico 18
FI - Finlandia 15
ES - Italia 12
AR - Argentina 11
BD - Bangladesh 11
IL - Israele 11
PL - Polonia 10
JP - Giappone 9
ZA - Sudafrica 8
IQ - Iraq 7
NL - Olanda 7
CH - Svizzera 6
SC - Seychelles 6
CO - Colombia 5
CZ - Repubblica Ceca 5
CW - ???statistics.table.value.countryCode.CW??? 4
EU - Europa 4
JO - Giordania 4
MY - Malesia 4
PK - Pakistan 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
JM - Giamaica 3
NI - Nicaragua 3
TH - Thailandia 3
UZ - Uzbekistan 3
AT - Austria 2
BE - Belgio 2
BG - Bulgaria 2
EE - Estonia 2
GP - Guadalupe 2
GT - Guatemala 2
ID - Indonesia 2
IR - Iran 2
KR - Corea 2
MA - Marocco 2
PR - Porto Rico 2
RS - Serbia 2
SA - Arabia Saudita 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
GD - Grenada 1
GR - Grecia 1
HT - Haiti 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SI - Slovenia 1
SV - El Salvador 1
TN - Tunisia 1
Totale 3.927
Città #
Singapore 372
Chandler 269
San Jose 207
Ashburn 169
Dublin 119
Jacksonville 110
Dallas 102
Council Bluffs 80
Beijing 75
Chieti 62
Princeton 58
Los Angeles 50
Southend 42
Dearborn 39
Santa Clara 34
Ho Chi Minh City 33
Hong Kong 30
Ann Arbor 28
Nanjing 26
Wilmington 26
Izmir 23
New York 21
North Bergen 20
Washington 19
Silver Spring 18
Hanoi 17
Redondo Beach 15
The Dalles 15
Dong Ket 13
Altamura 12
Cambridge 12
Milan 12
Orem 12
Buffalo 11
Montreal 10
Rome 10
Nanchang 9
Tokyo 9
Chicago 8
Jiaxing 8
Kunming 8
Varallo 8
Brooklyn 7
Columbus 7
Johannesburg 7
Moscow 7
Phoenix 7
Shanghai 7
Vittuone 7
Woodbridge 7
Amsterdam 6
Atlanta 6
Boardman 6
Boston 6
Ciudad de Villa de Álvarez 6
Denver 6
Lake Zurich 6
Las Vegas 6
London 6
Norwalk 6
Shenyang 6
São Paulo 6
Warsaw 6
Bellaterra 5
Chennai 5
Da Nang 5
Hefei 5
Monfalcone 5
Mount Pleasant 5
Poplar 5
Ankara 4
Falls Church 4
Frankfurt am Main 4
Geneva 4
Haiphong 4
Houston 4
Kingston 4
Monticello 4
Mumbai 4
Oklahoma City 4
Orlando 4
Sabadell 4
Tianjin 4
Willemstad 4
Amman 3
Baghdad 3
Bangkok 3
Bismarck 3
Bogotá 3
Chaguanas 3
Changsha 3
Civitanova Marche 3
Dhaka 3
Edinburgh 3
Fulton 3
Jinan 3
Killeen 3
Managua 3
Manchester 3
Mexico City 3
Totale 2.494
Nome #
Efficacy of phages and antibiotic-phage combinations against biofilm by Pseudomonas aeruginosa from cystic fibrosis patients 188
Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection. 182
Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm 175
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 166
Effect of levofloxacin on Stenotrophomonas maltophilia biofilm and its relationship with SmeDEF multidrug efflux pump expression under conditions relevant to the cystic fibrosis lung 154
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp pasteurianus 151
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus 146
Characterization of biofilm formation by Myroides odoratimimus isolated from post-traumatic calcaneal recurrent ulcer in diabetic patient 146
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 143
New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formed by a human wound-associated strain. 142
Microbial cooperation in cystic fibrosis: Stenotrophomonas maltophilia significantly modulates Pseudomonas aeruginosa virulence. 142
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 134
In vivo bacterial cooperation in cystic fibrosis: exposure to Stenotrophomonas maltophilia affects Pseudomonas aeruginosa virulence in murine model of acute lung infection. 132
Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study 130
In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions 129
In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression 125
Stenotrophomonas maltophilia mutant lacking flagella remains virulent in DBA/2N mice but is less efficient in stimulating TNF-α expression 124
Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens 123
Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis. 123
Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient 121
In Vitro Newly Isolated Environmental Phage Activity against Biofilms Preformed by Pseudomonas aeruginosa from Patients with Cystic Fibrosis 115
Modulation of biofilm formation by Stenotrophomonas maltophilia during chronic lung infection in cystic fibrosis patients: a longitudinal population study 113
Toward optimization of antimicrobial peptides for the treatment of multidrug resistant infections in cystic fibrosis. 110
“Indirect pathogenicity” in cystic fibrosis during pulmonary exacerbations: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in a Galleria mellonella model. 108
New insights in Staphylococcus pseudintermedius pathogenicity: Antibiotic-resistant biofilm formation by a human wound-associated strain 107
Individuation and evaluation of new bacteriophages for the treatment of cystic fibrosis biofilm-related lung infections caused by Pseudomonas aeruginosa. 105
Individuation and evaluation of new bacteriophages for the treatment of cystic fibrosis lung infection caused by Pseudomonas aeruginosa 102
Potential Novel Therapeutic Strategies in Cystic Fibrosis: Antimicrobial and Anti-Biofilm Activity of Natural and Designed Alpha-Helical Peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. 101
The importance of postmortem microbiological examination for the ex post diagnosis of infection: fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus. 98
Stenotrophomonas maltophilia phenotypic and genotypic diversity during a 10-year infection in the lungs of a cystic fibrosis patient 92
Toward optimization of a BMAP-derived antimicrobial peptide for the treatment of pulmonary infections caused by Pseudomonas aeruginosa in cystic fibrosis patients. 92
Cyclization of acyl thiosemicarbazides led to new Helicobacter pylori α-carbonic anhydrase inhibitors 51
A longitudinal population genomic study of Stenotrophomonas maltophilia in cystic fibrosis patients: expanding our knowledge about an emerging opportunistic pathogen. 17
Totale 4.087
Categoria #
all - tutte 16.740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.740


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022143 0 0 0 0 4 2 2 14 12 1 36 72
2022/2023586 47 85 54 77 40 106 24 43 75 5 23 7
2023/2024261 11 12 32 18 22 81 38 19 1 4 3 20
2024/2025463 23 111 82 23 15 40 4 12 57 26 46 24
2025/20261.337 83 34 146 151 168 47 270 68 115 117 114 24
2026/2027464 17 55 73 187 132 0 0 0 0 0 0 0
Totale 4.087